A RANDOMIZED PROSPECTIVE-STUDY ON THE EFFECT OF SHORT AND LONG BUSERELIN TREATMENT IN WOMEN WITH REPEATED UNSUCCESSFUL INVITRO FERTILIZATION (IVF) CYCLES DUE TO INADEQUATE OVARIAN RESPONSE

被引：21
作者：
DIRNFELD, M
GONEN, Y
LISSAK, A
GOLDMAN, S
KOIFMAN, M
SOROKIN, Y
ABRAMOVICI, H
机构：
[1] Department of Obstetrics and Gynecology, Carmel Hospital, Haifa, 34362
来源：
JOURNAL OF IN VITRO FERTILIZATION AND EMBRYO TRANSFER | 1991年 / 8卷 / 06期
关键词：
POOR RESPONDERS; GONADOTROPIN RELEASING HORMONE ANALOG; INVITRO FERTILIZATION; OVULATION INDUCTION;
D O I：
10.1007/BF01133025
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Fifty four women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response to stimulation with human menopausal gonadotropins (hMG) participated in this study. They were randomized to receive either gonadotropin releasing hormone agonist (GNRHa), Buserelin, prior to and during induction of ovulation by hMG (Group I-long protocol), or GnRHa starting on the first day of the cycle together with induction of ovulation by hMG (Group II-short protocol). Mean follicular phase serum luteinizing hormone (LH) and progesterone (P) levels were significantly lower in Group I than in Group II (P < 0.01). Cancellation rate was significantly lower in Group I than in Group II (P < 0.01). The long GNRHa protocol resulted in statistically significant lower cancellation rates, more oocytes per pickup (OPU), more embryos transferred per patient, and a higher pregnancy rate. Significantly more hMG ampoules and more treatments days were required in the long GNRHa protocol. Our data demonstrate that the use of GNRHa prior to and during ovarian stimulation with hMG offers a very good alternative for patients with repetitive unsuccessful IVF cycles due to inadequate response.
引用
收藏
页码：339 / 343
页数：5
相关论文
共 25 条
  • [1] Edwards R.G., Fishel S.B., Cohen J., Fehilly C.B., Purdy J.M., Slater J.M., Steptoe P.C., Webster J.M., Factors influencing the success of in vitro fertilization for alleviating human infer-tility, J Vitro Fert Embryo Transfer, 1, pp. 3-23, (1984)
  • [2] Lopata A., Concepts in human in vitro fertilization and embryo transfer, Fertil Steril, 40, (1983)
  • [3] Awadalla S.G., Friedman C.I., Chin N.O., Dodds W., Pank J.M., Kim M.H., Follicular stimulation for in vitro fertilization using pitutary suppression and human menopausal gonadotropins, Fertil Steril, 48, pp. 811-815, (1987)
  • [4] Lejeune B., Degueldre M., Camus M., Vekemans M., Opsomer L., Leroy F., In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadtropin administration, Fertil Steril, 45, pp. 377-383, (1986)
  • [5] Diamond M.P., Wentz A.C., Vaughn W.K., Webster B.W., Hebert C.M., Osteen K.G., Maxon W.S., Outcome of successive cycles of ovulation induction in the same individual, Fertil Steril, 43, pp. 369-372, (1985)
  • [6] Wildt L., Dietrich K., Van der Ven H., EL Hasani S., Hubner H., Klasen R., Ovarian hypenstimulation for in vitro fertilization controlled by GNRH agonist administered in combination with human menopausal gonadotropins, Hum Reprod, 1, pp. 15-19, (1986)
  • [7] Stanger J.D., Yovich J.L., Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase, Br J Obstet Gynecol, 92, pp. 385-393, (1985)
  • [8] Fleming R., Coutts J.R.T., Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression, Fertil Steril, 45, pp. 226-230, (1986)
  • [9] Fleming R., Adam A.H., Barlow D.H., Black W.P., Macnaughton M.C., Coutts J.E.T., A new systematic treatment for infertile women with abnormal hormone profiles, Br J Obstet Gynecol, 89, (1982)
  • [10] Smith J., Devroey P., Braeckmans P., Camus M., Khan I., Staerssen C., Van Waesberghe L., Wisanto A., Van Steirteghem A.C., Management of failed cycles in an IVF/GIFT Programme with the combination of GNRH analogue and HMG, Hum Reprod, 4, pp. 309-314, (1987)
123